Natixis Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-14,571
| Closed | -$626K | – | 1585 |
|
|
2023
Q3 | $626K | Sell |
14,571
-2,881
| -17% | -$123K | ﹤0.01% | 1305 |
|
|
2023
Q2 | $735K | Sell |
17,452
-376,039
| -96% | -$15.2M | ﹤0.01% | 1241 |
|
|
2023
Q1 | $14M | Buy |
393,491
+121,096
| +44% | +$4.39M | 0.05% | 400 |
|
|
2022
Q4 | $9.99M | Buy |
272,395
+48,169
| +21% | +$1.9M | 0.04% | 482 |
|
|
2022
Q3 | $10.6M | Sell |
224,226
-143,504
| -39% | -$9.27M | 0.04% | 417 |
|
|
2022
Q2 | $26.4M | Buy |
367,730
+42,475
| +13% | +$3.11M | 0.12% | 207 |
|
|
2022
Q1 | $26.3M | Buy |
325,255
+80,864
| +33% | +$6.84M | 0.1% | 225 |
|
|
2021
Q4 | $25.1M | Buy |
244,391
+5,821
| +2% | +$559K | 0.1% | 235 |
|
|
2021
Q3 | $20.9M | Buy |
238,570
+15,507
| +7% | +$1.4M | 0.09% | 242 |
|
|
2021
Q2 | $20M | Buy |
223,063
+98,688
| +79% | +$8.34M | 0.09% | 252 |
|
|
2021
Q1 | $9.43M | Buy |
124,375
+1,335
| +1% | +$101K | 0.05% | 405 |
|
|
2020
Q4 | $8.38M | Buy |
123,040
+29,174
| +31% | +$1.82M | 0.05% | 406 |
|
|
2020
Q3 | $4.99M | Buy |
93,866
+8,567
| +10% | +$510K | 0.03% | 525 |
|
|
2020
Q2 | $4.97M | Buy |
85,299
+59,573
| +232% | +$3.2M | 0.03% | 514 |
|
|
2020
Q1 | $1.01M | Buy |
25,726
+2,207
| +9% | +$129K | 0.01% | 906 |
|
|
2019
Q4 | $1.4M | Buy |
23,519
+1,828
| +8% | +$98.3K | 0.01% | 907 |
|
|
2019
Q3 | $1.15M | Buy |
21,691
+1,998
| +10% | +$103K | 0.01% | 899 |
|
|
2019
Q2 | $1.01M | Buy |
19,693
+685
| +4% | +$31.9K | 0.01% | 928 |
|
|
2019
Q1 | $984K | Buy |
19,008
+3,096
| +19% | +$150K | 0.01% | 917 |
|
|
2018
Q4 | $626K | Sell |
15,912
-1,040
| -6% | -$48.3K | 0.01% | 991 |
|
|
2018
Q3 | $874K | Buy |
16,952
+370
| +2% | +$18.1K | 0.01% | 976 |
|
|
2018
Q2 | $778K | Buy |
16,582
+1,858
| +13% | +$76.9K | 0.01% | 977 |
|
|
2018
Q1 | $523K | Buy |
14,724
+189
| +1% | +$7.4K | 0.01% | 1009 |
|
|
2017
Q4 | $634K | Buy |
+14,535
| New | +$679K | 0.01% | 959 |
|
|
2017
Q2 | – | Sell |
-37,748
| Closed | -$1.73M | – | 1070 |
|
|
2017
Q1 | $1.73M | Sell |
37,748
-11,469
| -23% | -$571K | 0.02% | 733 |
|
|
2016
Q4 | $2.59M | Buy |
+49,217
| New | +$2.38M | 0.03% | 606 |
|
Other funds holding SYNH
Natixis Advisors's SYNH Position: Q4 2023 in Review
Natixis Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2023, closing a stake of 14,571 shares — an estimated $626K sold.
Natixis Advisors first reported a position in SYNH in Q4 2016 and held it in 26 quarters. The position peaked at $26.4M in Q2 2022. 2 funds tracked by Wall St. Rank hold SYNH as of Q4 2023.
- Natixis Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2023 after selling out during the quarter.
- Natixis Advisors sold 14,571 Syneos Health, Inc. Class A Common Stock shares in Q4 2023, an estimated $626K.
- Natixis Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2016 and held it in 26 quarters.
- Natixis Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $26.4M in Q2 2022.
- 2 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2023.
Based on Natixis Advisors's 13F filing for Q4 2023, filed 6 Feb 2024.